Cargando…
Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy
BACKGROUND: Colorectal cancer is a common digestive cancer worldwide. As a comprehensive treatment for locally advanced rectal cancer (LARC), neoadjuvant therapy (NT) has been increasingly used as the standard treatment for clinical stage II/III rectal cancer. However, few patients achieve a complet...
Autores principales: | Wei, Fang-Ze, Mei, Shi-Wen, Chen, Jia-Nan, Wang, Zhi-Jie, Shen, Hai-Yu, Li, Juan, Zhao, Fu-Qiang, Liu, Zheng, Liu, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673964/ https://www.ncbi.nlm.nih.gov/pubmed/33268952 http://dx.doi.org/10.3748/wjg.v26.i42.6638 |
Ejemplares similares
-
Impact factors of lymph node retrieval on survival in locally advanced rectal cancer with neoadjuvant therapy
por: Mei, Shi-Wen, et al.
Publicado: (2020) -
Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients
por: Mei, Shi-Wen, et al.
Publicado: (2020) -
Low ligation has a lower anastomotic leakage rate after rectal cancer surgery
por: Chen, Jia-Nan, et al.
Publicado: (2020) -
Intraoperative intraperitoneal chemotherapy increases the incidence of anastomotic leakage after anterior resection of rectal tumors
por: Wang, Zhi-Jie, et al.
Publicado: (2019) -
Consolidation chemotherapy with capecitabine after neoadjuvant chemoradiotherapy in high-risk patients with locally advanced rectal cancer: Propensity score study
por: Sheng, Xue-Qing, et al.
Publicado: (2022)